Marty St. Clair

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

David A. Margolis, Juan González‐García, Hans-Jürgen Stellbrink et al. · The Lancet · 2017 · 504 citations

Medicine, Pharmacology, Pharmacotherapy +14

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora et al. · New England Journal of Medicine · 2020 · 464 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

Michael M. Lederman, Elizabeth Connick, Alan Landay et al. · The Journal of Infectious Diseases · 1998 · 428 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

Justin C. McArthur, Daniel McClernon, Michael F. Cronin et al. · Annals of Neurology · 1997 · 402 citations

Medicine, Infectious Diseases, Neurology +16

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Raymond F. Schinazi, A. McMillan, Deborah Cannon et al. · Antimicrobial Agents and Chemotherapy · 1992 · 291 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10